Viewing Study NCT07361705


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-31 @ 3:56 AM
Study NCT ID: NCT07361705
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-23
First Post: 2025-12-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module